Trial
NCT01395797
Pioglitazone for Heroin and for Nicotine Dependence
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
National Institute on Drug Abuse (NIDA); Omeros Corporation
Condition
Heroin Dependence
Intervention
PIO
Why stopped
The funding period ended.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-13